Form 8-K - Current report:
SEC Accession No. 0001193125-24-247017
Filing Date
2024-10-30
Accepted
2024-10-30 07:40:01
Documents
14
Period of Report
2024-10-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d891583d8k.htm   iXBRL 8-K 28105
2 EX-99.1 d891583dex991.htm EX-99.1 10335
  Complete submission text file 0001193125-24-247017.txt   162691

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mgnx-20241025.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgnx-20241025_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgnx-20241025_pre.xml EX-101.PRE 10813
17 EXTRACTED XBRL INSTANCE DOCUMENT d891583d8k_htm.xml XML 3535
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 241407469
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)